2004
February February; 9 (1): 1 - 117.	April April; 9 (2): 116 - 240.	June June; 9 (3): 241 - 357. Supplement: Targeting VEGF in Cancer Treatment. Supplement: Microtubule Stabilization in the Treatment of Solid Tumors: Role of the Taxanes. Supplement: The Future of ErbB-1 and ErbB-2 Pathway Inhibition in Breast Cancer: Targeting Multiple Receptors.
July July; 9 (4): 357 - 481.	September Supplement: Optimizing Bisphosphonate Therapy in Oncology. September; 9 (5): 482 - 598.	November November; 9 (6): 599 - 719. Supplement: Beyond Hemoglobin and Quality of Life: Exploring the Spectrum of Clinical Benefits with rHuEpo.
December Supplement: New Horizons for Topotecan: Important Advances in the Treatment of Lung Cancer.